These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9625507)
1. Prevalence of iatrogenic hyperthyroidism in a community hospital. Watsky JG; Koeniger MA J Am Board Fam Pract; 1998; 11(3):175-9. PubMed ID: 9625507 [TBL] [Abstract][Full Text] [Related]
2. Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy. Ross DS Mayo Clin Proc; 1988 Dec; 63(12):1223-9. PubMed ID: 3059080 [TBL] [Abstract][Full Text] [Related]
3. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Biondi B; Cooper DS Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821 [TBL] [Abstract][Full Text] [Related]
4. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575 [TBL] [Abstract][Full Text] [Related]
5. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease. De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104 [TBL] [Abstract][Full Text] [Related]
6. [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function]. Biondi B; Fazio S; Palmieri EA; Tremalaterra R; Angellotti G; Bonè F; Riccio G; Cittadini A; Lombardi G; Saccà L Cardiologia; 1999 May; 44(5):443-9. PubMed ID: 10389349 [TBL] [Abstract][Full Text] [Related]
7. Role of Subclinical Iatrogenic Hyperthyroidism in the Setting of Heart Disease and Arrhythmic Burden. Mastroianno S; Di Stolfo G; Maggio A; Pacilli M; Potenza DR; Massaro R; De Luca G; Russo A Endocr Metab Immune Disord Drug Targets; 2020; 20(6):959-962. PubMed ID: 31880254 [TBL] [Abstract][Full Text] [Related]
8. Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assay. Spencer CA; Lai-Rosenfeld AO; Guttler RB; LoPresti J; Marcus AO; Nimalasuriya A; Eigen A; Doss RC; Green BJ; Nicoloff JT J Clin Endocrinol Metab; 1986 Aug; 63(2):349-55. PubMed ID: 3088021 [TBL] [Abstract][Full Text] [Related]
9. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness. Franklyn JA; Black EG; Betteridge J; Sheppard MC J Clin Endocrinol Metab; 1994 Jun; 78(6):1368-71. PubMed ID: 8200938 [TBL] [Abstract][Full Text] [Related]
10. [Lipid abnormalities in elderly patients with subclinical hyperthyroidism]. Caparević Z; Stojanović D; Ilić V; Bojković G; Stojanović M Med Pregl; 2003; 56(11-12):564-7. PubMed ID: 15080051 [TBL] [Abstract][Full Text] [Related]
11. Use of a sensitive thyrotropin assay for monitoring treatment with levothyroxine. Watts NB Arch Intern Med; 1989 Feb; 149(2):309-12. PubMed ID: 2644903 [TBL] [Abstract][Full Text] [Related]
13. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer. Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605 [TBL] [Abstract][Full Text] [Related]
14. [Is there a need for treatment in subclinical hypo- and hyperthyroidism?]. Lerch M; Meier C; Staub JJ Ther Umsch; 1999 Jul; 56(7):369-73. PubMed ID: 10434773 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. Bayer MF; Kriss JP; McDougall IR J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528 [TBL] [Abstract][Full Text] [Related]
16. Free thyroid hormones and a third-generation TSH assay in the detection of hyperthyroidism during long-term thyroxine treatment in thyroid carcinoma patients. Taimela E; Koskinen P; Nuutila P; Nikkanen V; Saraste M; Taimela S; Irjala K Scand J Clin Lab Invest; 1995 Apr; 55(2):181-6. PubMed ID: 7667611 [TBL] [Abstract][Full Text] [Related]
17. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Aoki Y; Belin RM; Clickner R; Jeffries R; Phillips L; Mahaffey KR Thyroid; 2007 Dec; 17(12):1211-23. PubMed ID: 18177256 [TBL] [Abstract][Full Text] [Related]
18. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients. Wynne AG; Gharib H; Scheithauer BW; Davis DH; Freeman SL; Horvath E Am J Med; 1992 Jan; 92(1):15-24. PubMed ID: 1346235 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of procollagen III peptide as a marker of tissue hyperthyroidism in long-term treated women with TSH suppressive doses of thyroxine. Zulewski H; Siggelkow H; Walden C; Becker W; Hüfner M Exp Clin Endocrinol Diabetes; 1999; 107(3):190-4. PubMed ID: 10376444 [TBL] [Abstract][Full Text] [Related]